- Home
- KZR vs ICMB Comparison
KZR vs ICMB Comparison
Compare KZR & ICMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZR
- ICMB
- Stock Information
- Founded
- KZR 2015
- ICMB 2012
- Country
- KZR United States
- ICMB United States
- Employees
- KZR N/A
- ICMB N/A
- Industry
- KZR Biotechnology: Pharmaceutical Preparations
- ICMB Finance: Consumer Services
- Sector
- KZR Health Care
- ICMB Finance
- Exchange
- KZR Nasdaq
- ICMB Nasdaq
- Market Cap
- KZR 44.1M
- ICMB 44.8M
- IPO Year
- KZR 2018
- ICMB N/A
- Fundamental
- Price
- KZR $4.88
- ICMB $3.23
- Analyst Decision
- KZR Hold
- ICMB
- Analyst Count
- KZR 2
- ICMB 0
- Target Price
- KZR $9.00
- ICMB N/A
- AVG Volume (30 Days)
- KZR 22.4K
- ICMB 22.1K
- Earning Date
- KZR 03-25-2025
- ICMB 03-25-2025
- Dividend Yield
- KZR N/A
- ICMB 14.84%
- EPS Growth
- KZR N/A
- ICMB N/A
- EPS
- KZR N/A
- ICMB 0.45
- Revenue
- KZR N/A
- ICMB $23,360,165.00
- Revenue This Year
- KZR N/A
- ICMB N/A
- Revenue Next Year
- KZR N/A
- ICMB N/A
- P/E Ratio
- KZR N/A
- ICMB $7.17
- Revenue Growth
- KZR N/A
- ICMB N/A
- 52 Week Low
- KZR $4.54
- ICMB $2.91
- 52 Week High
- KZR $9.30
- ICMB $3.67
- Technical
- Relative Strength Index (RSI)
- KZR 31.03
- ICMB 50.78
- Support Level
- KZR $5.01
- ICMB $3.14
- Resistance Level
- KZR $6.37
- ICMB $3.30
- Average True Range (ATR)
- KZR 0.32
- ICMB 0.09
- MACD
- KZR -0.09
- ICMB -0.01
- Stochastic Oscillator
- KZR 18.58
- ICMB 38.57
About KZR Kezar Life Sciences Inc.
Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.